Back
The Travelers Companies Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
42
TRV
The Travelers Companies
Last Price:
$259.20
Seasonality Move:
-1.17%
Sell
46
ALNY
Alnylam Pharmaceuticals
Last Price:
$251.70
Seasonality Move:
20.34%
Sell
42
The Travelers Companies (TRV)
is a Sell
Is The Travelers Companies a Buy, Sell or Hold?
-
The current The Travelers Companies [TRV] share price is $259.16. The Score for TRV is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
TRV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $251.56. The Score for ALNY is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TRV Stock Price Chart
What is The Travelers Companies's stock price today?
-
The The Travelers Companies share price today is $259.16Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRV is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $251.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
TRV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1 | Buy |
Relative Strength Index (14 RSI): | 54.84 | Buy |
Chaikin Money Flow: | 519349 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (245.98 - 263.48) | Buy |
Bollinger Bands (100): | (240.53 - 259.07) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.62 | Sell |
Relative Strength Index (14 RSI): | 53.73 | Buy |
Chaikin Money Flow: | 623017 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (231.11 - 269.73) | Buy |
Bollinger Bands (100): | (237.02 - 266.92) | Sell |
TRV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 255.94 | Buy |
20-day SMA: | 253.39 | Buy |
50-day SMA: | 253.35 | Buy |
200-day SMA: | 240.99 | Buy |
8-day EMA: | 256.44 | Buy |
20-day EMA: | 254.53 | Buy |
50-day EMA: | 253 | Buy |
200-day EMA: | 240.96 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 237.7 | Buy |
20-day SMA: | 243.26 | Buy |
50-day SMA: | 249.78 | Buy |
200-day SMA: | 258.61 | Sell |
8-day EMA: | 241.27 | Buy |
20-day EMA: | 243.27 | Buy |
50-day EMA: | 248.83 | Buy |
200-day EMA: | 244.06 | Buy |
The Travelers Companies Earnings Growth & TRV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.54 per share, a decrease next quarter of $1.25 per share, a decrease this year of $0.23 per share, and an increase next year of $5.97 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $1.38 per share, an increase this year of $0.96 per share, and an increase next year of $2.88 per share.
The Travelers Companies Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |